Dinsmore Christopher 4
4 · Kronos Bio, Inc. · Filed Feb 17, 2023
Insider Transaction Report
Form 4
Kronos Bio, Inc.KRON
Dinsmore Christopher
Chief Scientific Officer
Transactions
- Award
Common Stock
2023-02-15+119,882→ 291,292 total - Award
Employee Stock Option (Right to Buy)
2023-02-15+179,824→ 179,824 totalExercise: $2.09Exp: 2033-02-14→ Common Stock (179,824 underlying)
Footnotes (2)
- [F1]Includes an aggregate of 8,474 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on the following dates: 959 shares on June 30, 2021, 1,039 shares on December 31, 2021 and 6,476 shares on December 30, 2022.
- [F2]1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant.